SBC Medical Group
SBC
50 hedge funds and large institutions have $6.07M invested in SBC Medical Group in 2026 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 18 reducing their positions, and 2 closing their positions.
595% more capital inflows, than outflows
Capital inflows: $1.96M | Capital outflows: $282K
450% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 2
19% more funds holding
Funds holding: 42 → 50 (+8)
0.13% more ownership
Funds ownership: 1.29% → 1.42% (+0.13%)
22% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Segall Bryant & Hamill
Chicago,
Illinois
|
+$339K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$141K |
| 3 |
Mariner
Overland Park,
Kansas
|
+$100K |
| 4 |
Lumbard & Kellner
Hollis,
New Hampshire
|
+$72.1K |
| 5 |
Goldman Sachs
New York
|
+$57.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$60.9K |
| 2 |
Charles Schwab
San Francisco,
California
|
-$38.1K |
| 3 |
Wells Fargo
San Francisco,
California
|
-$34.9K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$34K |
| 5 |
Morgan Stanley
New York
|
-$29.7K |
SBC Hedge Fund Activity: Q1 2026 in Review
50 of the 8,226 institutional investors tracked by Wall St. Rank reported a position in SBC Medical Group (SBC) for Q1 2026, worth a combined $6.07M — up 6.7% from $5.69M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new SBC positions and 2 closed out — a net gain of 9 holders — while 14 added to existing stakes and 18 trimmed.
The largest buyer was Segall Bryant & Hamill, opening a new position worth an estimated $339K. The largest seller was Barclays, cutting an estimated $60.9K.
- 50 institutional investors held SBC Medical Group (SBC) as of Q1 2026, up from 42 in Q4 2025.
- Funds reported $6.07M of SBC Medical Group stock for Q1 2026, up 6.7% quarter-over-quarter.
- 11 funds opened new SBC Medical Group positions in Q1 2026 and 2 closed out, a net change of +9 holders.
- The largest SBC Medical Group buyer in Q1 2026 was Segall Bryant & Hamill, an estimated $339K added.
- The largest SBC Medical Group seller in Q1 2026 was Barclays, an estimated $60.9K sold.
Based on aggregated 13F filings for Q1 2026.